| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-06 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-06 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-06 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.22 | 9e-06 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.13 | 1e-05 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-05 |